Companies will work together to optimize renal disease trials
RESEARCH TRIANGLE PARK, N.C. & MINNEAPOLIS--(BUSINESS WIRE)--
Quintiles,
the world’s largest provider of product development and integrated
healthcare services, and DaVita
Clinical Research, a wholly-owned subsidiary of DaVita HealthCare
Partners Inc., a leader in kidney care, today announced a global
strategic alliance. The alliance combines DaVita’s world-class clinical
care and expansive footprint of research sites with Quintiles’
industry-leading operational delivery and therapeutic expertise in
clinical trials.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20160802005399/en/
Quintiles-DaVita Infographic (Graphic: Business Wire)
“Through this alliance with DaVita Clinical Research, we will have the
power to provide biopharmaceutical customers with nephrology expertise
and global delivery capabilities to truly advance clinical research,”
said Jeanne Hecht, senior vice president and global head, Site and
Patient Networks at Quintiles. “Our aim is to align our processes to
reduce cycle times and accelerate clinical trial execution. Moreover, we
will be able to alleviate the burden on patients participating in renal
disease trials by incorporating clinical research into clinical care.”
DaVita Clinical Research is part of DaVita Healthcare Partners, a
leading provider of kidney care as well as one of the largest US
healthcare providers, providing care to more than one million patients
who may be available for potential trial enrollment. DaVita Clinical
Research brings to this alliance data-driven trial feasibility
expertise, trial sites in Europe and Latin America, its deep clinical
knowledge of renal patients as well as an established research
infrastructure with DaVita dialysis facilities and 30 years’ experience
conducting clinical trials across therapeutic areas.
With progressively complex protocol designs and the increasing demand
for broad patient population participation, nephrology clinical studies
can pose a series of challenges. Through this strategic alliance, the
two companies align to provide capabilities and solutions for overcoming
these challenges to deliver end-to-end support for renal disease
clinical trials. By leveraging Quintiles’ protocol modeling and
feasibility, in combination with DaVita’s extensive patient
understanding, biopharmaceutical customers will be able to take
advantage of the combined assets of both companies to progress their
clinical programs.
“This alliance allows novel approaches to clinical development and
clinical trial execution specifically in site identification,
participant enrollment and study design,” said Amy Young, vice president
and general manager of DaVita Clinical Research. “We are excited about
the opportunities this affords our organizations to provide innovative
solutions to the biopharmaceutical industry and the participants we
serve.”
Learn more about the strategic alliance between Quintiles and DaVita
Clinical Research by visiting www.quintiles.com/library/infographics/quintiles-davita.
About Quintiles
Quintiles (NYSE: Q) helps biopharma and other healthcare companies
improve their probability of success by connecting insights from our
deep scientific, therapeutic and analytics expertise with superior
delivery for better outcomes. From advisory through operations,
Quintiles is the world’s largest provider of product development and
integrated healthcare services, including commercial and observational
solutions. Conducting operations in approximately 100 countries,
Quintiles is a member of the FORTUNE 500 and has been named to FORTUNE’s
list of the “World’s Most Admired Companies.” To learn more, visit www.quintiles.com.
About DaVita HealthCare Partners
DaVita HealthCare Partners Inc., a Fortune 500® company, is the parent
company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney
Care is a leading provider of kidney care in the United States,
delivering dialysis services to patients with chronic kidney failure and
end stage renal disease. As of March 31, 2016, DaVita Kidney Care
operated or provided administrative services at 2,278 outpatient
dialysis centers located in the United States serving approximately
180,000 patients. The company also operated 124 outpatient dialysis
centers located in 10 countries outside the United States. HealthCare
Partners manages and operates medical groups and affiliated physician
networks in Arizona, California, Nevada, New Mexico, Florida, Colorado
and Washington in its pursuit to deliver excellent-quality health care
in a dignified and compassionate manner. As of March 31, 2016 HealthCare
Partners provided integrated care management for approximately 790,000
patients. For more information, please visit
DaVitaHealthCarePartners.com.
About DaVita Clinical Research (DCR)
DaVita
Clinical Research (DCR), a wholly owned subsidiary of DaVita
HealthCare Partners Inc.,uses its extensive, applied database and
real-world healthcare experience to assist pharmaceutical and medical
device companies in the design, recruitment and completion of
retrospective, prospective and pragmatic clinical trials. DCR’s
scientific and clinical expertise spans the lifecycle of product
development with more than 175 client companies. DCR’s Early
Clinical Research unit (Phase I-IIa) and Late
Phase Clinical Research (Phase IIb through post-marketing) network
of physicians and investigative sites, Real
World Healthcare Data,and Medical
Communications are focused on providing world-class research in both
complex/specialty populations and therapeutic areas, and especially in
CKD and ESRD populations. To learn more about DCR, visit www.davitaclinicalresearch.com.
Click
here to subscribe to Mobile Alerts for Quintiles.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160802005399/en/
Source: Quintiles